Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 6

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 6
---
 of cybersecurity, data privacy, legal, compliance and regulatory matters, and other critical evolving areas, such as corporate sustainability initiatives. • Independent directors conduct regular executive sessions without management present. • Directors maintain open communication and strong working relationships among themselves and have regular and direct access to management. • Directors conduct a robust annual Board of Directors and committee self-assessment process. • We have a majority voting standard for uncontested elections of directors. • We have robust related party transaction standards for any direct or indirect involvement of a director or member of management in the company’s business activities. • We have robust stock ownership guidelines that require our C-Level executive officers and the non-employee directors on our Board of Directors to hold shares of our common stock, as further discussed herein. • We have a clawback policy, adopted in accordance with the Nasdaq Stock Market listing standards and compliant with the Securities and Exchange Commission (the “SEC”) rules, that provides for the recoupment of certain executive officer incentive compensation in the event we are required to restate our financial statements.

| One-Year Terms                                          
 For all directors commencing at our 2026 annual meeting |

| Majority Voting Standard               
 For uncontested elections of directors |

| Only Independent                     
 Directors                            
 On all Board of Directors committees |

| Regular Executive Sessions                                    
 Conducted by independent directors without management present |

#### 6Veracyte2025 Proxy Statement
| PROPOSAL ONE |

Election of Directors

Directors and Nominees

The number of directors is currently set at nine. Following approval by our stockholders at the 2023 Annual Meeting, we filed a Restated Certificate to implement a declassification of the Board of Directors over a three-year period and provide for the annual election of directors for one-year terms, commencing upon the expiration of the directors’ then-current terms. As of the date of the Annual Meeting, five directors are either serving or completing a three-year term, two directors are serving or completing a one-year term and two directors are serving or completing an initial term, as follows: • Robert S. Epstein , M.D., M.S . , and Evan Jones were elected to the Board of Directors at our 2023 Annual Meeting of Stockholders, and their three-year terms will expire at the Annual Meeting of Stockholders to be held in 2026 (the “2026 Annual Meeting”); • Muna Bhanji and Marc Stapley were elected to the Board of Directors at our 2024 Annual Meeting of Stockholders, and their one-year terms